{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:11:55Z","timestamp":1794265915244,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-16067770"],"award-info":[{"award-number":["RS-2025-16067770"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008003","name":"Korea Institute of Radiological and Medical Sciences","doi-asserted-by":"publisher","award":["50461-2025"],"award-info":[{"award-number":["50461-2025"]}],"id":[{"id":"10.13039\/501100008003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008003","name":"Korea Institute of Radiological and Medical Sciences","doi-asserted-by":"publisher","award":["50547-2025"],"award-info":[{"award-number":["50547-2025"]}],"id":[{"id":"10.13039\/501100008003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-025-01369-6","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:43:33Z","timestamp":1767422613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["225Ac-NOTA-trastuzumab human dosimetry using inter-radionuclide and biological half-life based allometric extrapolation method"],"prefix":"10.1186","volume":"16","author":[{"given":"Muath","family":"Almaslamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangsan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Keun","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"1369_CR1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S140671","author":"A Yordanova","year":"2017","unstructured":"Yordanova A, Eppard E, K\u00fcrpig S, Bundschuh RA, Sch\u00f6nberger S, Gonzalez-Carmona M, et al. Theranostics in nuclear medicine practice. Onco Targets Ther. 2017. https:\/\/doi.org\/10.2147\/OTT.S140671.","journal-title":"Onco Targets Ther"},{"key":"1369_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2967\/jnumed.118.220566","volume":"60","author":"T Langbein","year":"2019","unstructured":"Langbein T, Weber WA, Eiber M. Future of theranostics: an outlook on precision oncology in nuclear medicine. J Nucl Med. 2019;60:S13\u20139.","journal-title":"J Nucl Med"},{"key":"1369_CR3","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1148\/rg.2020200021","volume":"40","author":"JF Gomes Marin","year":"2020","unstructured":"Gomes Marin JF, Nunes RF, Coutinho AM, Zaniboni EC, Costa LB, Barbosa FG, et al. Theranostics in nuclear medicine: emerging and re-emerging integrated imaging and therapies in the era of precision oncology. Radiographics. 2020;40:1715\u201340.","journal-title":"Radiographics"},{"key":"1369_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph10020056","volume":"10","author":"F R\u00f6sch","year":"2017","unstructured":"R\u00f6sch F, Herzog H, Qaim SM. The beginning and development of the theranostic approach in nuclear medicine, as exemplified by the radionuclide pair 86Y and 90Y. Pharmaceuticals. 2017;10:56.","journal-title":"Pharmaceuticals"},{"key":"1369_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S170879","author":"B Gutfilen","year":"2018","unstructured":"Gutfilen B, Souza SAL, Valentini G. Copper-64: a real theranostic agent. Drug Des Devel Ther. 2018. https:\/\/doi.org\/10.2147\/DDDT.S170879.","journal-title":"Drug Des Devel Ther"},{"key":"1369_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2967\/jnumed.118.210294","volume":"60","author":"S-K Woo","year":"2019","unstructured":"Woo S-K, Jang SJ, Seo M-J, Park JH, Kim BS, Kim EJ, et al. Development of 64Cu-NOTA-trastuzumab for HER2 targeting: a radiopharmaceutical with improved pharmacokinetics for human studies. J Nucl Med. 2019;60:26\u201333.","journal-title":"J Nucl Med"},{"issue":"9","key":"1369_CR7","first-page":"6254","volume":"7","author":"A Nassar","year":"2014","unstructured":"Nassar A, Khoor A, Radhakrishnan R, Radhakrishnan A, Cohen C. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas. Int J Clin Exp Pathol. 2014;7(9):6254.","journal-title":"Int J Clin Exp Pathol"},{"key":"1369_CR8","doi-asserted-by":"crossref","unstructured":"Moja L, Tagliabue L, Balduzzi S, Parmelli E, Pistotti V, Guarneri V, D\u2019Amico R. 2012. Trastuzumab containing regimens for early breast cancer. Cochrane database of systematic reviews, (4).","DOI":"10.1002\/14651858.CD006243.pub2"},{"issue":"7","key":"1369_CR9","first-page":"1018","volume":"66","author":"A Mansur","year":"2025","unstructured":"Mansur A, McConathy JE, Stringer-Reasor E, Rocque G, Khoury K, Eltoum N, et al. Quantitative [89Zr] Zr-Trastuzumab PET and diffusion-weighted MRI for characterization of metastatic HER2-positive breast cancer with PET\/MRI. J Nucl Med. 2025;66(7):1018\u201326.","journal-title":"J Nucl Med"},{"issue":"16","key":"1369_CR10","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3390\/diagnostics13162649","volume":"13","author":"I Lee","year":"2023","unstructured":"Lee I, Kim MH, Lee K, Oh K, Lim H, Ahn JH, et al. Comparison of the effects of DOTA and NOTA chelators on 64Cu-Cudotadipep and 64Cu-Cunotadipep for prostate cancer. Diagnostics. 2023;13(16):2649.","journal-title":"Diagnostics"},{"key":"1369_CR11","doi-asserted-by":"crossref","unstructured":"Sgouros G, Frey E, Wahl R, He B, Prideaux A, Hobbs R. Three-dimensional imaging-based radiobiological dosimetry. Semin. Nucl. Med., vol. 38, Elsevier; 2008, pp. 321\u201334.","DOI":"10.1053\/j.semnuclmed.2008.05.008"},{"key":"1369_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.14316\/pmp.2016.27.2.86","volume":"27","author":"YS Park","year":"2016","unstructured":"Park YS, Lee YJ, Young WK, Ji H, Kim KB, Kang JH, et al. Image-based absorbed dosimetry of radioisotope. Prog Med Phys. 2016;27:86\u201392.","journal-title":"Prog Med Phys"},{"key":"1369_CR13","doi-asserted-by":"publisher","unstructured":"Sgouros G. Dosimetry, Radiobiology and synthetic lethality: radiopharmaceutical therapy (RPT) with alpha-particle-emitters. Semin Nucl Med. 2020;50(2):115\u201392. } https:\/\/doi.org\/10.1053\/j.semnuclmed.2019.11.002}","DOI":"10.1053\/j.semnuclmed.2019.11.002"},{"key":"1369_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13550-022-00893-z","volume":"12","author":"F Cicone","year":"2022","unstructured":"Cicone F, Viertl D, Deno\u00ebl T, Stabin MG, Prior JO, Gnesin S. Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules. EJNMMI Res. 2022;12:21.","journal-title":"EJNMMI Res"},{"key":"1369_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12149-013-0685-9","volume":"27","author":"M Sakata","year":"2013","unstructured":"Sakata M, Oda K, Toyohara J, Ishii K, Nariai T, Ishiwata K. Direct comparison of radiation dosimetry of six PET tracers using human whole-body imaging and murine biodistribution studies. Ann Nucl Med. 2013;27:285\u201396.","journal-title":"Ann Nucl Med"},{"key":"1369_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6438196","author":"S Beykan","year":"2019","unstructured":"Beykan S, Fani M, Jensen SB, Nicolas G, Wild D, Kaufmann J, et al. In vivo biokinetics of 177Lu-OPS201 in mice and pigs as a model for predicting human dosimetry. Contrast Media Mol Imaging. 2019. https:\/\/doi.org\/10.1155\/2019\/6438196.","journal-title":"Contrast Media Mol Imaging"},{"key":"1369_CR17","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the Second-Generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46(6):1023-7."},{"key":"1369_CR18","unstructured":"Stabin M, Farmer A. OLINDA\/EXM 2.0: The new generation dosimetry modeling code 2012."},{"key":"1369_CR19","first-page":"248","volume":"16","author":"AS Kirschner","year":"1975","unstructured":"Kirschner AS, Ice RD, Beierwaltes WH. Radiation dosimetry of 131I-19-iodocholesterol: the pitfalls of using tissue concentration data\u2014reply. J Nucl Med. 1975;16:248\u20139.","journal-title":"J Nucl Med"},{"key":"1369_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0146-6453(03)00002-2","volume":"32","author":"J Valentin","year":"2002","unstructured":"Valentin J. Basic anatomical and physiological data for use in radiological protection: reference values: ICRP publication 89. Ann ICRP. 2002;32:1\u2013277.","journal-title":"Ann ICRP"},{"key":"1369_CR21","unstructured":"Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. Oak Ridge Associated Universities, TN (United States); 1999."},{"key":"1369_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/0023677021911731","volume":"36","author":"SL Lindstedt","year":"2002","unstructured":"Lindstedt SL, Schaeffer PJ. Use of allometry in predicting anatomical and physiological parameters of mammals. Lab Anim. 2002;36:1\u201319.","journal-title":"Lab Anim"},{"key":"1369_CR23","doi-asserted-by":"crossref","unstructured":"Charles MW. ICRP Publication 103: Recommendations of the ICRP 2008.","DOI":"10.1093\/rpd\/ncn187"},{"key":"1369_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00259-017-3817-y","volume":"45","author":"C Kratochwil","year":"2018","unstructured":"Kratochwil C, Schmidt K, Afshar-Oromieh A, Bruchertseifer F, Rathke H, Morgenstern A, et al. Targeted alpha therapy of mCRPC: dosimetry estimate of 213 Bismuth-PSMA-617. Eur J Nucl Med Mol Imaging. 2018;45:31\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1369_CR25","doi-asserted-by":"crossref","unstructured":"Feinendegen LE and McClure JJ, Meeting report - Alpha-emitters for medical therapy - Workshop of the United States Department of Energy - Denver, Colorado, May 30-31,1996. Radiat Res, 1997. 148(2): p. 195\u2013201.","DOI":"10.2307\/3579579"},{"key":"1369_CR26","first-page":"149","volume":"41","author":"MG Stabin","year":"2000","unstructured":"Stabin MG, Konijnenberg MW. Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes. J Nucl Med. 2000;41:149\u201360.","journal-title":"J Nucl Med"},{"key":"1369_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2967\/jnumed.116.175695","volume":"58","author":"Z Cai","year":"2017","unstructured":"Cai Z, Kwon YL, Reilly RM. Monte Carlo N-particle (MCNP) modeling of the cellular dosimetry of 64Cu: comparison with MIRDcell S values and implications for studies of its cytotoxic effects. J Nucl Med. 2017;58:339\u201345.","journal-title":"J Nucl Med"},{"key":"1369_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11307-014-0783-7","volume":"17","author":"S Huang","year":"2015","unstructured":"Huang S, Bolch WE, Lee C, Van Brocklin HF, Pampaloni MH, Hawkins RA, et al. Patient-specific dosimetry using pretherapy [124I] m-iodobenzylguanidine ([124I] mIBG) dynamic PET\/CT imaging before [131I] mIBG targeted radionuclide therapy for neuroblastoma. Mol Imaging Biol. 2015;17:284\u201394.","journal-title":"Mol Imaging Biol"},{"key":"1369_CR29","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.bjc.6604940","volume":"100","author":"SM Tovey","year":"2009","unstructured":"Tovey SM, Brown S, Doughty JC, Mallon EA, Cooke TG, Edwards J. Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours. Br J Cancer. 2009;100:680\u20133.","journal-title":"Br J Cancer"},{"key":"1369_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21037\/cco.2016.05.10","volume":"5","author":"N Liao","year":"2016","unstructured":"Liao N. HER2-positive breast cancer, how far away from the cure?-on the current situation of anti-HER2 therapy in breast cancer treatment and survival of patients. Chin Clin Oncol. 2016;5:41.","journal-title":"Chin Clin Oncol"},{"issue":"6","key":"1369_CR31","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2967\/jnumed.116.186338","volume":"59","author":"S Poty","year":"2018","unstructured":"Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. \u03b1-emitters for radiotherapy: from basic radiochemistry to clinical studies\u2014part 1. J Nucl Med. 2018;59(6):878\u201384.","journal-title":"J Nucl Med"},{"key":"1369_CR32","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1088\/1361-6560\/aa6a99","volume":"62","author":"AKH Robertson","year":"2017","unstructured":"Robertson AKH, Ramogida CF, Rodriguez-Rodriguez C, Blinder S, Kunz P, Sossi V, et al. Multi-isotope SPECT imaging of the 225Ac decay chain: feasibility studies. Phys Med Biol. 2017;62:4406.","journal-title":"Phys Med Biol"},{"issue":"1","key":"1369_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41181-024-00239-1","volume":"9","author":"EL Hooijman","year":"2024","unstructured":"Hooijman EL, Radchenko V, Ling SW, Konijnenberg M, Brabander T, Koolen SL, et al. Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-) clinical perspectives. EJNMMI Radiopharm Chem. 2024;9(1):9.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"1369_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/molecules23030581","volume":"23","author":"J Kozempel","year":"2018","unstructured":"Kozempel J, Mokhodoeva O, Vlk M. Progress in targeted alpha-particle therapy. What we learned about recoils release from in vivo generators. Molecules. 2018;23:581.","journal-title":"Molecules"},{"key":"1369_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1039\/C3CS60304K","volume":"43","author":"EW Price","year":"2014","unstructured":"Price EW, Orvig C. Matching chelators to radiometals for radiopharmaceuticals. Chem Soc Rev. 2014;43:260\u201390.","journal-title":"Chem Soc Rev"},{"issue":"2","key":"1369_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-021-06427-w","volume":"191","author":"G Lewis Phillips","year":"2022","unstructured":"Lewis Phillips G, Guo J, Kiefer JR, Proctor W, Yadav B, Dybdal D, N. and, Shen BQ. Trastuzumab does not bind rat or mouse ErbB2\/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics. Breast Cancer Res Treat. 2022;191(2):303\u201317.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1369_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","volume":"157","author":"V Sharma","year":"2009","unstructured":"Sharma V, McNeill JH. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol. 2009;157(6):907\u201321.","journal-title":"Br J Pharmacol"},{"key":"1369_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.apradiso.2013.12.008","volume":"85","author":"G Wang","year":"2014","unstructured":"Wang G, de Kruijff R, \u00e1M, Rol A, Thijssen L, Mendes E, Morgenstern A, et al. Retention studies of recoiling daughter nuclides of 225Ac in polymer vesicles. Appl Radiat Isot. 2014;85:45\u201353.","journal-title":"Appl Radiat Isot"},{"key":"1369_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/ph8020321","volume":"8","author":"RM De Kruijff","year":"2015","unstructured":"De Kruijff RM, Wolterbeek HT, Denkova AG. A critical review of alpha radionuclide therapy\u2014how to deal with recoiling daughters? Pharmaceuticals. 2015;8:321\u201336.","journal-title":"Pharmaceuticals"},{"key":"1369_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s002040000150","volume":"74","author":"BT Leussink","year":"2000","unstructured":"Leussink BT, Slikkerveer A, Krauwinkel WJJ, van der Voet GB, de Heer E, de Wolff FA, et al. Bismuth biokinetics and kidney histopathology after bismuth overdose in rats. Arch Toxicol. 2000;74:349\u201355.","journal-title":"Arch Toxicol"},{"key":"1369_CR41","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/antibiotics11121741","volume":"11","author":"LE Pelepenko","year":"2022","unstructured":"Pelepenko LE, Janini ACP, Gomes BPFA, de-Jesus-Soares A, Marciano MA. Effects of bismuth exposure on the human kidney\u2014a. Syst Rev Antibiot. 2022;11:1741.","journal-title":"Syst Rev Antibiot"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01369-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:39:33Z","timestamp":1770043173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-025-01369-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01369-6","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Korean Ministry of Food and Drug Safety (MFDS) and the Institutional Review Board of KIRAMS (IRB No.: KIRAMS 2017-09-006-020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"20"}}